BCL2 and neoplasm: Importantly, isovitexine inhibited tumor growth and reduced tumor size of U2OS-SC xenografts in nude mice, which was accompanied by decreased CD133 protein levels, elevated apoptotic index, downregulation of PCNA expression, reduced DNMT1 activity and expression, increased miR-34a and decreased Bcl-2 levels [254].